Metrics as of 10/17/2026, 02:07 AM (Berlin time), refresh in progress.
Gerresheimer Stock
Gerresheimer AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- Germany
- CEO
- Uwe Ferdinand Röhrhoff
- Employees
- 13,528
- Market cap
- €1.1 B
- IPO
- 11/06/2007
Gerresheimer AG is a global supplier in the healthcare sector based in Düsseldorf, Germany. Founded in 1864, the company specializes in the production and sale of packaging solutions and sophisticated drug delivery systems. The business operates through three distinct divisions. The Plastics & Devices segment provides…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Gerresheimer stock: price history
1D
+6.1%
1W
+6.2%
1M
+10.1%
6M
+42.8%
YTD
+10.4%
1Y
+12.3%
2Y
-63.2%
5Y
-62.0%
10Y
-57.0%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~101% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Gerresheimer
Gerresheimer stock metrics
P/E
-2.62
P/B
1.1
EV/EBITDA
12.98
RETURN ON EQUITY
-10.3%
NET MARGIN
-20.7%
DEBT/EQUITY
2.31
DIVIDEND YIELD
0.0%
AS OF
28/02/2026
Free float & liquidity
FREE FLOAT
92.8%
FLOAT SHARES
32,048,630
AVG. DAILY VOLUME (30D)
126,516
Dividends
Comparable stocks
Frequently asked questions about Gerresheimer stock
What does Gerresheimer do?
Gerresheimer AG is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in Germany.
The CEO is Uwe Ferdinand Röhrhoff, the company employs around 13,528 people.
The IPO was on 11/06/2007; the stock trades on XETRA under the ticker GXI.DE.
When does Gerresheimer report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 101% stronger than usual.
Does Gerresheimer pay a dividend?
Yes. The last dividend was €0.04 per share, ex-date 06/06/2025, paid on 10/06/2025.
The dividend yield is 0.0% (as of 28/02/2026).
Which stocks are comparable to Gerresheimer?
Comparable stocks include Sartorius, Anbio Biotechnology, Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum and Baxter International.
How can I get Gerresheimer stock analyzed?
Clicking "Analyze stock" lets five strategies assess Gerresheimer against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.